Skip to main content
. Author manuscript; available in PMC: 2019 Jan 1.
Published in final edited form as: Mol Cancer Ther. 2017 Nov 15;17(1):107–118. doi: 10.1158/1535-7163.MCT-16-0922

Table 1. Clinical characteristics of tumor from which CCA PDX models were derived.

The tumor tissue used to generate PDX models were obtained from consented patients undergoing surgical resection (CCA1-CCA4) or biopsy (CCA5) as part of standard of care for treatment of CCA.

ID TNM1 Stage Grade Sub Class LN2 met L.I3 P.I.4 pT5 (cm)
CCA1 pT2N1 IIB G3 EHCC Y Y Y 1.8
CCA2 pT3N0 IIA G2-G3 EHCC N Y N 3.5
CCA3 pT3N1 IIB G3 EHCC Y Y Y 1.3
CCA4 pT3N1 IIB G1 EHCC Y N Y 1.2
CCA5 met6 IV n/a IHCC n/a n/a n/a n/a
1

TNM staging system. T represents the size and extent of the primary tumor; N represents the number of lymph nodes involved; M indicates presence of metastasis.

2

Lymph node metastases present: Yes/No

3

Lymphovascular invasion

4

Perineural invasion

5

Size of primary tumor

6

Metastases

n/a: not available